Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 12.15% on an annualized basis producing an average annual return of 20.56%. Currently, Vertex Pharmaceuticals has a market capitalization of $118.76 billion.
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 20 years ago, it would be worth $4,227.04 today based on a price of $461.17 for VRTX at the time of writing.
Vertex Pharmaceuticals's Performance Over Last 20 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.